This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 1998 Apr 21;97(15):1436-9.

doi: 10.1161/01.cir.97.15.1436.

Statin trials and goals of cholesterol-lowering therapy

PMID: 9576422
DOI: 10.1161/01.cir.97.15.1436

Editorial

Statin trials and goals of cholesterol-lowering therapy

S M Grundy. Circulation. 1998.

. 1998 Apr 21;97(15):1436-9.

doi: 10.1161/01.cir.97.15.1436.

Author

PMID: 9576422
DOI: 10.1161/01.cir.97.15.1436

No abstract available

PubMed Disclaimer

Comment in

Goals for cholesterol lowering.
Stankler L. Stankler L. Circulation. 1999 May 11;99(18):2477. Circulation. 1999. PMID: 10318741 No abstract available.

Comment on

Influence of pravastatin and plasma lipids on clinical events in the West of Scotland Coronary Prevention Study (WOSCOPS).
[No authors listed] [No authors listed] Circulation. 1998 Apr 21;97(15):1440-5. doi: 10.1161/01.cir.97.15.1440. Circulation. 1998. PMID: 9576423 Clinical Trial.
Relationship between plasma LDL concentrations during treatment with pravastatin and recurrent coronary events in the Cholesterol and Recurrent Events trial.
Sacks FM, Moyé LA, Davis BR, Cole TG, Rouleau JL, Nash DT, Pfeffer MA, Braunwald E. Sacks FM, et al. Circulation. 1998 Apr 21;97(15):1446-52. doi: 10.1161/01.cir.97.15.1446. Circulation. 1998. PMID: 9576424 Clinical Trial.
Lipoprotein changes and reduction in the incidence of major coronary heart disease events in the Scandinavian Simvastatin Survival Study (4S).
Pedersen TR, Olsson AG, Faergeman O, Kjekshus J, Wedel H, Berg K, Wilhelmsen L, Haghfelt T, Thorgeirsson G, Pyörälä K, Miettinen T, Christophersen B, Tobert JA, Musliner TA, Cook TJ. Pedersen TR, et al. Circulation. 1998 Apr 21;97(15):1453-60. doi: 10.1161/01.cir.97.15.1453. Circulation. 1998. PMID: 9576425 Clinical Trial.

Similar articles

[LDL cholesterol in normal range. The lower the better? Implications of the GREACE study].
März W. März W. MMW Fortschr Med. 2003 Dec 11;145(50):46-9. MMW Fortschr Med. 2003. PMID: 14963971 Review. German.
Statin therapy in older persons: pertinent issues.
Grundy SM. Grundy SM. Arch Intern Med. 2002 Jun 24;162(12):1329-31. doi: 10.1001/archinte.162.12.1329. Arch Intern Med. 2002. PMID: 12076230 No abstract available.
Benefits of fibrate drugs in coronary heart disease patients with normal cholesterol levels.
Havel RJ. Havel RJ. Circulation. 1997 Oct 7;96(7):2113-4. doi: 10.1161/01.cir.96.7.2113. Circulation. 1997. PMID: 9337175 No abstract available.
Hypolipidemic drugs in coronary artery disease.
Bittar GB. Bittar GB. Ann Intern Med. 1997 Jun 1;126(11):916-7. doi: 10.7326/0003-4819-126-11-199706010-00019. Ann Intern Med. 1997. PMID: 9163300 No abstract available.
Effects of lipid lowering therapy on progression of coronary and carotid artery disease.
Ballantyne CM, Herd JA, Dunn JK, Jones PH, Farmer JA, Gotto AM Jr. Ballantyne CM, et al. Curr Opin Lipidol. 1997 Dec;8(6):354-61. doi: 10.1097/00041433-199712000-00006. Curr Opin Lipidol. 1997. PMID: 9412776 Review.

See all similar articles

Cited by

Caffeine-free hawk tea lowers cholesterol by reducing free cholesterol uptake and the production of very-low-density lipoprotein.
Feng J, Yang J, Chang Y, Qiao L, Dang H, Luo K, Guo H, An Y, Ma C, Shao H, Tian J, Yuan Y, Xie L, Xing W, Cheng J. Feng J, et al. Commun Biol. 2019 May 8;2:173. doi: 10.1038/s42003-019-0396-4. eCollection 2019. Commun Biol. 2019. PMID: 31098406 Free PMC article.
Effects of policosanol on borderline to mildly elevated serum total cholesterol levels: a prospective, double-blind, placebo-controlled, parallel-group, comparative study.
Castaño G, Más R, Fernández J, López E, Illnait J, Fernández L, Mesa M. Castaño G, et al. Curr Ther Res Clin Exp. 2003 Sep;64(8):522-37. doi: 10.1016/j.curtheres.2003.09.002. Curr Ther Res Clin Exp. 2003. PMID: 24944402 Free PMC article.
Recombinant murine fibroblast growth factor 21 ameliorates obesity-related inflammation in monosodium glutamate-induced obesity rats.
Wang WF, Li SM, Ren GP, Zheng W, Lu YJ, Yu YH, Xu WJ, Li TH, Zhou LH, Liu Y, Li DS. Wang WF, et al. Endocrine. 2015 May;49(1):119-29. doi: 10.1007/s12020-014-0433-5. Epub 2014 Oct 12. Endocrine. 2015. PMID: 25306889
Fibrates and high-dose statins to prevent coronary heart disease events.
Jones PH. Jones PH. Curr Cardiol Rep. 1999 Sep;1(3):223-4. doi: 10.1007/s11886-999-0026-8. Curr Cardiol Rep. 1999. PMID: 10980845 Review. No abstract available.
Who should receive HMG CoA reductase inhibitors?
Teo KK, Burton JR. Teo KK, et al. Drugs. 2002;62(12):1707-15. doi: 10.2165/00003495-200262120-00001. Drugs. 2002. PMID: 12149041 Review.

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Other Literature Sources
- The Lens - Patent Citations Database
Medical
- MedlinePlus Health Information